Sign in
Join
Click here - to use the wp menu builder
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Create an account
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Search
Type here...
Search
Home
Trending
Analysis
Research Reports
Contact Us
START FREE TRAIL
My account
Get into your account.
Login
Register
Search
Type here...
Search
Home
Trending
Analysis
Research Reports
Contact Us
START FREE TRAIL
My account
Get into your account.
Login
Register
Log In
Profile
Log Out
type here...
Search
Facebook
Instagram
Twitter
Youtube
Log In
Profile
Log Out
type here...
Search
Facebook
Instagram
Twitter
Youtube
Home
About Us
Trending
Analysis
Research Reports
Contact Us
Search
START FREE TRIAL
My account
Get into your account.
Login
Register
Home
About Us
Trending
Analysis
Research Reports
Contact Us
Search
START FREE TRIAL
My account
Get into your account.
Login
Register
Tag:
Healthcare
Healthcare
Technology & AI
Healthcare
M&A
Consumer & Retail
Miscellaneous
This Telehealth Stock Rally By RFK Jr. Looks Like Policy; It’s Actually A Margin SHIFT
Healthcare
Ishan Majumdar
-
April 17, 2026
Hims & Hers Health (NYSE:HIMS) did not report a surprise quarter, launch a blockbuster product, or raise guidance when...
Eli Lilly’s Foundayo & The GLP-1 Pivot From Innovation to Access Control!
Healthcare
Ishan Majumdar
-
April 13, 2026
Most coverage of Eli Lilly’s(NYSE:LLY) Foundayo launch has treated it like the next round in the company’s fight with...
The “Boring” Healthcare Stock Making A $5 Billion POWER MOVE!
M&A
Ishan M.
-
April 13, 2026
The market loves excitement. But money is often made in boredom. That is what makes Gilead Sciences (NASDAQ:GILD) such...
This Biotech Stock Already Has A Blockbuster; So Why Is It ACQUIRING Another Rare Disease Asset?
Healthcare
Ishan M.
-
April 13, 2026
There are biotech stories that look obvious, and then there are biotech stories that quietly change shape right in...
This “Broken” Biotech Just Forced Wall Street To Blink
M&A
Ishan Majumdar
-
April 13, 2026
Apellis Pharmaceuticals (NASDAQ:APLS) did not suddenly discover a miracle on Tuesday. What changed was the price investors were willing...
This Medical Device Stock Just Got CRUSHED On One Hidden Number; Did Wall Street Misread It?
Healthcare
Ishan Majumdar
-
April 13, 2026
Boston Scientific (NYSE:BSX) spent the weekend putting forward what looked, at first glance, like a clinically solid case for...
A First-In-Class Biotech Is Still Trading Below Its Strategic Value Today
Healthcare
Ishan Majumdar
-
April 13, 2026
A mid-cap biotech with the first approved therapy in a large, long-underfunded liver disease category is not supposed to...
Is Align A Classic Activist Win, Or A HARDER Consumer Story?
Healthcare
Ishan Majumdar
-
March 19, 2026
Align Technology (NASDAQ:ALGN) has become a useful test case for a very modern market question. What happens when Wall...
Agilent’s $950M Biocare Acquisition Could Unlock A Powerful Recurring Revenue Flywheel
M&A
Ishan Majumdar
-
March 14, 2026
The diagnostics and life sciences equipment industry rarely stands still. But recent developments around Agilent Technologies (NYSE:A) have drawn...
Qiagen Just Dropped Two Magic Words—And Wall Street Heard “Buyout”
Healthcare
Ishan Majumdar
-
March 7, 2026
Qiagen (NYSE:QGEN) just did the thing companies do right before Wall Street starts whispering louder. On March 2, CEO...
Is Merck’s HIV Win Really About Keytruda?
Healthcare
Ishan Majumdar
-
February 28, 2026
When Merck & Co. (NYSE:MRK) reported Phase 3 data showing its two-drug HIV regimen of doravirine and islatravir matched...
Did Novo Nordisk’s Trial Miss Just Hand Lilly The Edge?
Healthcare
Ishan Majumdar
-
February 28, 2026
It has been a bruising few weeks for Novo Nordisk (NYSE:NVO). First came the clinical disappointment: CagriSema, the company’s...
Load more
This Telehealth Stock Rally By RFK Jr. Looks Like Policy; It’s Actually A Margin SHIFT
Healthcare
Ishan Majumdar
-
April 17, 2026
Hims & Hers Health (NYSE:HIMS) did not report a surprise quarter, launch a blockbuster product, or raise guidance when...
Eli Lilly’s Foundayo & The GLP-1 Pivot From Innovation to Access Control!
Healthcare
Ishan Majumdar
-
April 10, 2026
Most coverage of Eli Lilly’s(NYSE:LLY) Foundayo launch has treated it like the next round in the company’s fight with...
The “Boring” Healthcare Stock Making A $5 Billion POWER MOVE!
M&A
Ishan M.
-
April 8, 2026
The market loves excitement. But money is often made in boredom. That is what makes Gilead Sciences (NASDAQ:GILD) such...
This Biotech Stock Already Has A Blockbuster; So Why Is It ACQUIRING Another Rare Disease Asset?
Healthcare
Ishan M.
-
April 6, 2026
There are biotech stories that look obvious, and then there are biotech stories that quietly change shape right in...
This “Broken” Biotech Just Forced Wall Street To Blink
M&A
Ishan Majumdar
-
April 1, 2026
Apellis Pharmaceuticals (NASDAQ:APLS) did not suddenly discover a miracle on Tuesday. What changed was the price investors were willing...
This Medical Device Stock Just Got CRUSHED On One Hidden Number; Did Wall Street Misread It?
Healthcare
Ishan Majumdar
-
March 31, 2026
Boston Scientific (NYSE:BSX) spent the weekend putting forward what looked, at first glance, like a clinically solid case for...
A First-In-Class Biotech Is Still Trading Below Its Strategic Value Today
Healthcare
Ishan Majumdar
-
March 27, 2026
A mid-cap biotech with the first approved therapy in a large, long-underfunded liver disease category is not supposed to...
Is Align A Classic Activist Win, Or A HARDER Consumer Story?
Healthcare
Ishan Majumdar
-
March 19, 2026
Align Technology (NASDAQ:ALGN) has become a useful test case for a very modern market question. What happens when Wall...
Agilent’s $950M Biocare Acquisition Could Unlock A Powerful Recurring Revenue Flywheel
M&A
Ishan Majumdar
-
March 10, 2026
The diagnostics and life sciences equipment industry rarely stands still. But recent developments around Agilent Technologies (NYSE:A) have drawn...
Qiagen Just Dropped Two Magic Words—And Wall Street Heard “Buyout”
Healthcare
Ishan Majumdar
-
March 3, 2026
Qiagen (NYSE:QGEN) just did the thing companies do right before Wall Street starts whispering louder. On March 2, CEO...
Is Merck’s HIV Win Really About Keytruda?
Healthcare
Ishan Majumdar
-
February 26, 2026
When Merck & Co. (NYSE:MRK) reported Phase 3 data showing its two-drug HIV regimen of doravirine and islatravir matched...
Did Novo Nordisk’s Trial Miss Just Hand Lilly The Edge?
Healthcare
Ishan Majumdar
-
February 25, 2026
It has been a bruising few weeks for Novo Nordisk (NYSE:NVO). First came the clinical disappointment: CagriSema, the company’s...